Innovations in Intelligent Aesthetics
In the world of aesthetic medicine, the demand for effective, evidence-based solutions continues to evolve. At the forefront of this movement is Sisram Medical Ltd's subsidiary, Alma, which recently showcased its vision for the future of Intelligent Aesthetics at an influential global congress. The event served as a significant platform where the latest advancements were shared with industry leaders and practitioners.
Transformative Clinical Evidence Presented
During the congress, held in early 2026, Alma highlighted new clinical findings that underscore its commitment to advanced scar management and rejuvenation. The presentations emphasized the smart, technology-driven approaches that Alma has pioneered in the field, enhancing the techniques practitioners can use for various aesthetic treatments.
Cutting-Edge Laser Technologies
Alma's innovative multi-technology laser platforms take center stage in these presentations. They showcased how advanced laser-based rejuvenation treatments can effectively serve as foundational elements of modern aesthetic care. Additionally, the unique ability to utilize multiple wavelengths within a single platform for tattoo removal represents a significant advancement in precision and efficacy within the industry.
Expanding Health and Beauty Solutions
One of the standout presentations featured clinical studies on the Alma Hybrid platform. This technology has shown promising results in managing keloid scars when used alongside surgical interventions and trans-epidermal steroid delivery. Furthermore, the congress provided insights into acne and acne scar management, complemented by live demonstrations of award-winning treatments such as Harmony Bio-Boost.
Insights from Industry Leaders
Mr. Eyal Ben David, Chief Executive Officer of Sisram, expressed the importance of the IMCAS platform. He noted how it is shaping the future of medical aesthetics by promoting rigorous clinical evidence and technological innovation. By enhancing precision diagnostics and personalized treatment planning, Alma is empowering healthcare practitioners to elevate patient outcomes significantly.
Future Directions of Aesthetic Practices
Alongside Mr. David, Mr. Lior Dayan, Chairman of Sisram, participated in a prominent economic forum at the congress, joining other industry leaders to discuss the impact of intelligent technologies on the medical aesthetics landscape. This dialogue centered on the transformative effects of clinical insights on practice developments in the sector.
About Sisram Medical Ltd
With a legacy of over 25 years, Sisram Medical Ltd (1696.HK) emerges as a global leader in medical aesthetic solutions, specializing in Energy-Based Devices (EBD). Their comprehensive ecosystem includes a diverse array of technologies, injectables, and diagnostic tools, serving over 110 countries. Recognized for groundbreaking innovations and a relentless commitment to enhancing patient care, Sisram has set high standards for safety and efficacy in aesthetic treatments.
Frequently Asked Questions
What innovations did Alma present at the IMCAS World Congress?
Alma showcased advancements in energy-based devices focusing on scar management and rejuvenation, including multi-technology laser platforms and the Alma Hybrid system.
Who is leading Sisram Medical Ltd?
Mr. Eyal Ben David serves as the CEO of Sisram Medical Ltd, driving the company's vision and innovations in aesthetic medicine.
What is the significance of IMCAS for the industry?
IMCAS is a crucial platform for sharing scientific advancements and innovative practices in medical aesthetics, shaping the future of aesthetic treatments.
How does Sisram Medical support practitioners?
Sisram Medical provides evidence-based solutions and advanced technologies, enabling practitioners to enhance patient care and outcomes.
What is the focus of Sisram's aesthetic solutions?
Sisram Medical focuses on integrating various aesthetic technologies, offering personalized solutions that cater to the evolving needs of practitioners and patients.
